Cipla Quarterly Results for Trading Insights

In Sept 2025, Cipla (CIPLA) reported revenue ₹7,716 Cr and net profit ₹1,353 Cr — revenue +7.9% YoY. For annual financials, live price and key ratios, visit CIPLA stock price BSE.

Latest Quarter Net Profit
₹1,353 Cr
QSept 2025
Quarterly Results

CIPLA Quarterly Results — Revenue, Profit & EPS Highlights

Cipla latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with CIPLA stock valuation models to assess whether the stock is under or overvalued.

  • Revenue of ₹7,716 Cr in Sept 2025 (+12.0% vs Mar 2025, +7.9% vs Sept 2024)
  • Net Profit of ₹1,353 Cr in Sept 2025 (+11.4% vs Mar 2025, +3.7% vs Sept 2024)
  • EBITDA of ₹2,022 Cr in Sept 2025 (+19.3% vs Mar 2025)
  • Operating Margin of 24.0% in Sept 2025 (+3.0pp vs Mar 2025)
  • Earnings Per Share of ₹16.73 in Sept 2025 (+10.6% vs Mar 2025)

Cipla Quarterly Results — Revenue, EBITDA, Net Profit & EPS

CIPLA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 7,716 6,887 7,096 7,169 7,152 12.0% 7.9%
Net Profit (₹ Cr) 1,353 1,214 1,292 674 1,305 - -
EBITDA (₹ Cr) 2,022 1,695 1,916 1,074 1,986 - -
EPS (₹) 16.73 15.13 16.07 8.37 16.13 - -
Operating Margin (%) 24.0% 21.0% 24.0% 12.0% 26.0% - -

CIPLA Share Price Trend — 1-Year Movement Across Quarterly Results

Cipla 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse Cipla shareholding analysis to track promoter, FII and institutional holdings.

Profitability Ratios

Profit Margin 17.5%
EBITDA Margin 26.2%
Operating Margin 24.0%
ROE (Annual) 17.3%

Balance Sheet Highlights

Total Assets ₹37,387 Cr
Total Equity ₹31,289 Cr
Current Assets ₹23,249 Cr
Current Liabilities ₹614 Cr

Cash Flow Analysis

Operating Cash Flow ₹5,005 Cr
Investing Cash Flow ₹-3,682 Cr
Financing Cash Flow ₹-1,293 Cr
Net Cash Flow ₹30 Cr

Current Market Data

Current Price ₹1211.10
Exchange NSE
Last Updated Apr 13, 2026

Revenue Trend (₹ Cr)

Dec 2025 7,169
Jun 2025 7,096
Mar 2025 6,887
Sept 2025 7,716

Net Profit Trend (₹ Cr)

Dec 2025 674
Jun 2025 1,292
Mar 2025 1,214
Sept 2025 1,353

Operating Margin Trend (%)

Dec 2025 12.0%
Jun 2025 24.0%
Mar 2025 21.0%
Sept 2025 24.0%

CIPLA vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Cipla latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹396,418.12 Cr 1652.2 14,875 3,125 +10.8% - 21.0% 127.1
Divis Laboratories
Sept 2025 		₹162,373.86 Cr 6070.0 2,860 689 +7.1% - 24.1% 233.7
Torrent Pharmaceuti…
Sept 2025 		₹140,630.85 Cr 4181.0 3,219 591 +11.3% - 18.4% 238.4
Lupin
Sept 2025 		₹106,664.75 Cr 2315.1 6,921 1,485 +23.2% - 21.5% 71.5
Dr Reddys Laborator…
Sept 2025 		₹102,844.71 Cr 1235.9 9,135 1,337 +1.1% - 14.6% 76.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores